GB2181053B - Pharmaceutical formulations with controlled release of the active substance - Google Patents

Pharmaceutical formulations with controlled release of the active substance

Info

Publication number
GB2181053B
GB2181053B GB8623389A GB8623389A GB2181053B GB 2181053 B GB2181053 B GB 2181053B GB 8623389 A GB8623389 A GB 8623389A GB 8623389 A GB8623389 A GB 8623389A GB 2181053 B GB2181053 B GB 2181053B
Authority
GB
United Kingdom
Prior art keywords
active substance
controlled release
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8623389A
Other versions
GB8623389D0 (en
GB2181053A (en
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Priority to GB8623389A priority Critical patent/GB2181053B/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8623389D0 publication Critical patent/GB8623389D0/en
Publication of GB2181053A publication Critical patent/GB2181053A/en
Publication of GB2181053B publication Critical patent/GB2181053B/en
Application granted granted Critical
Priority to CY1622A priority patent/CY1622A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8623389A 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance Expired - Lifetime GB2181053B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB8623389A GB2181053B (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
CY1622A CY1622A (en) 1985-10-01 1992-07-10 Pharmaceutical formulations with controlled release of the active substance

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions
GB8623389A GB2181053B (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance

Publications (3)

Publication Number Publication Date
GB8623389D0 GB8623389D0 (en) 1986-11-05
GB2181053A GB2181053A (en) 1987-04-15
GB2181053B true GB2181053B (en) 1990-05-23

Family

ID=27546915

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8623389A Expired - Lifetime GB2181053B (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance

Country Status (2)

Country Link
CY (1) CY1622A (en)
GB (1) GB2181053B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
DE3776269D1 (en) * 1986-11-03 1992-03-05 Schering Corp LABETALOL TABLET WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES.
YU47044B (en) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. PROCEDURE FOR OBTAINING HIGH-MOLECULAR HYDROXYPROPYL-METHYLCELLULOSE PROLONGED TABLETS
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
FR2677886B1 (en) * 1991-06-18 1995-03-31 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF INDAPAMIDE AFTER ORAL ADMINISTRATION.
EP2441445A1 (en) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles
EP2441446A1 (en) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations
EP2543364A1 (en) * 2010-10-14 2013-01-09 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1135966A (en) * 1966-01-06 1968-12-11 Ceskoslovenska Akademie Ved Improvements in or relating to sustained-release medicaments
GB2111386A (en) * 1981-12-18 1983-07-06 Forest Laboratories Prolonged release compositions
GB2117239A (en) * 1982-03-26 1983-10-12 Forest Laboratories Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
GB2154874A (en) * 1984-02-29 1985-09-18 Sandoz Ltd Bromocriptine compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1135966A (en) * 1966-01-06 1968-12-11 Ceskoslovenska Akademie Ved Improvements in or relating to sustained-release medicaments
GB2111386A (en) * 1981-12-18 1983-07-06 Forest Laboratories Prolonged release compositions
GB2117239A (en) * 1982-03-26 1983-10-12 Forest Laboratories Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
GB2154874A (en) * 1984-02-29 1985-09-18 Sandoz Ltd Bromocriptine compositions

Also Published As

Publication number Publication date
CY1622A (en) 1992-07-10
GB8623389D0 (en) 1986-11-05
GB2181053A (en) 1987-04-15

Similar Documents

Publication Publication Date Title
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
GB2211413B (en) Pharmaceutical formulations comprising microcapsules
EP0282951A3 (en) Controlled release preparations of active materials
GB8502974D0 (en) Sustained release of active substance
GB8504099D0 (en) Physiologically active substances
GB8630870D0 (en) Active support substance
PH20391A (en) Controlled release pharmaceutical preparations
IL74049A0 (en) Controlled release liquid dosage pharmaceutical formulations
NO862373D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIENOPYRIDONES.
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
IL79163A0 (en) 1,8-bridged 4-quinolone-3-carboxylic acids,their preparation,medicaments containing them and their use for the preparation of medicaments
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
GR862457B (en) Pharmaceutical formulations with controlled release of the active substance
HUT42679A (en) Insecticidal and acaricidal compositions comprising alkanoyl-anilide derivatives as active substance and process for preparing the active substances
GB8801863D0 (en) Pharmaceutical formulations with controlled drug release
ZA867507B (en) Pharmaceutical formulations with controlled release of the active substance
AU6322686A (en) Pharmaceutical formulations with controlled release of the active substance
ZA86705B (en) Controlled release insecticide
ZA875937B (en) Pharmaceutical formulations comprising microcapsules
IE850071L (en) Controlled release pharmaceutical formulations
GB8503221D0 (en) Pharmaceutical formulations
IT8648494A0 (en) PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE OF THE ACTIVE SUBSTANCE
HUT43925A (en) Insecticides comprising trihalogen-imidazole derivatives as active substance and process for preparing the active substances
EG17797A (en) Controlled release formulation
IL68779A0 (en) Pharmaceutical mixture with controlled release of active substance

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 20060928